AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao, Austin Dulak, Wenxian Wang, Philip Petteruti, Ian L. Dale, Scott Boiko, Tony Cheung, Jingwen Zhang, Shenghua Wen, Lillian Castriotta, Deborah Lawson, Michael Collins, Larry Bao, Miika J. Ahdesmaki, Graeme Walker, Greg O'Connor, Tammie C. Yeh, Alfred A. Rabow, Jonathan R. Dry, Corinne Reimer, Paul Lyne, Gordon B. Mills, Stephen E. Fawell, Michael J. Waring, Michael Zinda, Edwin Clark, Huawei Chen

Open source

DOI: 10.1158/1535-7163.mct-16-0141
Published: 2016-11-01
Container: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-16-0141,
  title = {AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies},
  author = {Garrett W. Rhyasen and Maureen M. Hattersley and Yi Yao and Austin Dulak and Wenxian Wang and Philip Petteruti and Ian L. Dale and Scott Boiko and Tony Cheung and Jingwen Zhang and Shenghua Wen and Lillian Castriotta and Deborah Lawson and Michael Collins and Larry Bao and Miika J. Ahdesmaki and Graeme Walker and Greg O'Connor and Tammie C. Yeh and Alfred A. Rabow and Jonathan R. Dry and Corinne Reimer and Paul Lyne and Gordon B. Mills and Stephen E. Fawell and Michael J. Waring and Michael Zinda and Edwin Clark and Huawei Chen},
  year = {2016},
  journal = {Molecular Cancer Therapeutics},
  doi = {10.1158/1535-7163.mct-16-0141},
  url = {https://doi.org/10.1158/1535-7163.mct-16-0141}
}

RIS

TY  - JOUR
TI  - AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
AU  - Garrett W. Rhyasen
AU  - Maureen M. Hattersley
AU  - Yi Yao
AU  - Austin Dulak
AU  - Wenxian Wang
AU  - Philip Petteruti
AU  - Ian L. Dale
AU  - Scott Boiko
AU  - Tony Cheung
AU  - Jingwen Zhang
AU  - Shenghua Wen
AU  - Lillian Castriotta
AU  - Deborah Lawson
AU  - Michael Collins
AU  - Larry Bao
AU  - Miika J. Ahdesmaki
AU  - Graeme Walker
AU  - Greg O'Connor
AU  - Tammie C. Yeh
AU  - Alfred A. Rabow
AU  - Jonathan R. Dry
AU  - Corinne Reimer
AU  - Paul Lyne
AU  - Gordon B. Mills
AU  - Stephen E. Fawell
AU  - Michael J. Waring
AU  - Michael Zinda
AU  - Edwin Clark
AU  - Huawei Chen
PY  - 2016
JO  - Molecular Cancer Therapeutics
DO  - 10.1158/1535-7163.mct-16-0141
UR  - https://doi.org/10.1158/1535-7163.mct-16-0141
ER  -

APA

Rhyasen, G. W., Hattersley, M. M., Yao, Y., Dulak, A., Wang, W., Petteruti, P., Dale, I. L., Boiko, S., Cheung, T., Zhang, J., Wen, S., Castriotta, L., Lawson, D., Collins, M., Bao, L., Ahdesmaki, M. J., Walker, G., O'Connor, G., Yeh, T. C., Rabow, A. A., Dry, J. R., Reimer, C., Lyne, P., Mills, G. B., Fawell, S. E., Waring, M. J., Zinda, M., Clark, E., & Chen, H. (2016). AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-16-0141

Source records

crossref · retrieved 2026-09-26T00:43:56.618Z